Silicon Laboratories Inc. (NASDAQ:SLAB) Shares Purchased by Pacer Advisors Inc.

Pacer Advisors Inc. raised its stake in Silicon Laboratories Inc. (NASDAQ:SLAB) by 1.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,839 shares of the semiconductor company’s stock after purchasing an additional 87 shares during the quarter. Pacer Advisors Inc.’s holdings in Silicon Laboratories were worth $601,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Procyon Advisors LLC lifted its stake in shares of Silicon Laboratories by 4.4% in the 4th quarter. Procyon Advisors LLC now owns 3,176 shares of the semiconductor company’s stock valued at $395,000 after purchasing an additional 133 shares in the last quarter. Advisors Asset Management Inc. lifted its position in Silicon Laboratories by 159.4% during the third quarter. Advisors Asset Management Inc. now owns 275 shares of the semiconductor company’s stock valued at $32,000 after buying an additional 169 shares in the last quarter. GAMMA Investing LLC grew its stake in Silicon Laboratories by 84.1% during the third quarter. GAMMA Investing LLC now owns 497 shares of the semiconductor company’s stock worth $57,000 after buying an additional 227 shares during the period. US Bancorp DE raised its stake in shares of Silicon Laboratories by 14.0% in the 3rd quarter. US Bancorp DE now owns 1,892 shares of the semiconductor company’s stock valued at $219,000 after acquiring an additional 232 shares during the period. Finally, Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Silicon Laboratories by 12.3% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 2,128 shares of the semiconductor company’s stock valued at $246,000 after acquiring an additional 233 shares in the last quarter.

Silicon Laboratories Stock Down 0.6 %

Shares of NASDAQ:SLAB opened at $134.79 on Tuesday. The company has a market cap of $4.37 billion, a PE ratio of -18.21 and a beta of 1.17. The firm has a 50-day simple moving average of $126.96 and a 200 day simple moving average of $116.33. Silicon Laboratories Inc. has a fifty-two week low of $94.00 and a fifty-two week high of $154.91.

Silicon Laboratories (NASDAQ:SLAB) last issued its earnings results on Monday, November 4th. The semiconductor company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.20) by $0.07. Silicon Laboratories had a negative return on equity of 12.60% and a negative net margin of 46.93%. The firm had revenue of $166.00 million for the quarter, compared to analyst estimates of $165.50 million. During the same period last year, the company earned $0.48 earnings per share. The firm’s revenue for the quarter was down 18.5% on a year-over-year basis. As a group, research analysts forecast that Silicon Laboratories Inc. will post -3.56 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently commented on SLAB. StockNews.com raised Silicon Laboratories to a “sell” rating in a research report on Friday, November 8th. Barclays raised their target price on Silicon Laboratories from $75.00 to $120.00 and gave the company an “equal weight” rating in a research note on Friday, January 17th. Benchmark reiterated a “hold” rating on shares of Silicon Laboratories in a research note on Tuesday, November 5th. Susquehanna started coverage on Silicon Laboratories in a research note on Tuesday, December 17th. They set a “neutral” rating and a $130.00 price objective for the company. Finally, JPMorgan Chase & Co. cut their target price on Silicon Laboratories from $150.00 to $135.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 5th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, Silicon Laboratories currently has an average rating of “Hold” and a consensus target price of $133.56.

Insider Buying and Selling

In other Silicon Laboratories news, Director William G. Bock sold 2,000 shares of the firm’s stock in a transaction dated Wednesday, January 22nd. The shares were sold at an average price of $140.77, for a total transaction of $281,540.00. Following the transaction, the director now owns 32,115 shares of the company’s stock, valued at approximately $4,520,828.55. This trade represents a 5.86 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 1.72% of the company’s stock.

Silicon Laboratories Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.